跳至主要内容
临床试验/NCT06311032
NCT06311032已完成不适用

Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2023年3月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
1
主要终点
Number of Decisions to Stop Surveillance Imaging

研究概览

简要总结

The main objective of this study is to determine how physicians make decisions regarding surveillance of Intraductal Papillary Mucinous Neoplasm's (IPMN) of the pancreas.

详细描述

The study will employ a survey design that poses physicians with a series of three clinical case vignettes. Each vignette describes an IPMN of varying severity, and the physician will be asked determine whether they would continue or discontinue clinical surveillance in each case.

This will be a double-blinded randomized survey study, featuring two arms. Providers will be randomized to either be provided with, or not provided with a risk stratification tool (DART-1) when presented with their clinical case vignettes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Membership in either the PACYFIC or PRECEDE consortiums
  • Physician with expertise in the management of IPMN
  • Able and willing to complete survey

排除标准

  • Not a member of either the PACYFIC or PRECEDE consortiums
  • Not a physician with expertise in the management of IPMN

结局指标

主要结局

Number of Decisions to Stop Surveillance Imaging

时间窗: Day 1

Number of Decisions to Continue Surveillance Imaging

时间窗: Day 1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验